vs

Side-by-side financial comparison of FIRST MERCHANTS CORP (FRME) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

FIRST MERCHANTS CORP is the larger business by last-quarter revenue ($157.1M vs $83.1M, roughly 1.9× PROCEPT BioRobotics Corp). FIRST MERCHANTS CORP runs the higher net margin — 17.9% vs -38.1%, a 56.0% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -0.9%).

First Merchants Corporation is a financial holding company in Central Indiana, headquartered in Muncie, Indiana. The Corporation includes First Merchants Bank and First Merchants Private Wealth Advisors. The company is listed on the NASDAQ as FRME. As of March 2023, total asset size of First Merchants Corporation was $18.2 billion. First Merchants offers commercial banking, personal banking, and investment advisor services.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

FRME vs PRCT — Head-to-Head

Bigger by revenue
FRME
FRME
1.9× larger
FRME
$157.1M
$83.1M
PRCT
Higher net margin
FRME
FRME
56.0% more per $
FRME
17.9%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-0.9%
FRME

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
FRME
FRME
PRCT
PRCT
Revenue
$157.1M
$83.1M
Net Profit
$28.2M
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
17.9%
-38.1%
Revenue YoY
20.2%
Net Profit YoY
-49.1%
-27.9%
EPS (diluted)
$0.45
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRME
FRME
PRCT
PRCT
Q1 26
$157.1M
$83.1M
Q4 25
$172.2M
$76.4M
Q3 25
$166.1M
$83.3M
Q2 25
$164.3M
$79.2M
Q1 25
$160.3M
$69.2M
Q4 24
$177.1M
$68.2M
Q3 24
$156.0M
$58.4M
Q2 24
$159.9M
$53.4M
Net Profit
FRME
FRME
PRCT
PRCT
Q1 26
$28.2M
$-31.6M
Q4 25
$57.1M
$-29.8M
Q3 25
$56.8M
$-21.4M
Q2 25
$56.8M
$-19.6M
Q1 25
$55.3M
$-24.7M
Q4 24
$64.3M
$-18.9M
Q3 24
$49.2M
$-21.0M
Q2 24
$39.9M
$-25.6M
Gross Margin
FRME
FRME
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
FRME
FRME
PRCT
PRCT
Q1 26
-4.1%
Q4 25
38.0%
-40.6%
Q3 25
39.3%
-27.8%
Q2 25
39.6%
-28.0%
Q1 25
39.4%
-39.7%
Q4 24
43.3%
-28.9%
Q3 24
36.1%
-38.4%
Q2 24
27.5%
-50.3%
Net Margin
FRME
FRME
PRCT
PRCT
Q1 26
17.9%
-38.1%
Q4 25
33.1%
-39.1%
Q3 25
34.2%
-25.7%
Q2 25
34.6%
-24.7%
Q1 25
34.5%
-35.8%
Q4 24
36.3%
-27.6%
Q3 24
31.5%
-35.9%
Q2 24
25.0%
-48.0%
EPS (diluted)
FRME
FRME
PRCT
PRCT
Q1 26
$0.45
$-0.56
Q4 25
$0.98
$-0.54
Q3 25
$0.98
$-0.38
Q2 25
$0.98
$-0.35
Q1 25
$0.94
$-0.45
Q4 24
$1.09
$-0.34
Q3 24
$0.84
$-0.40
Q2 24
$0.68
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRME
FRME
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$2.7B
$347.7M
Total Assets
$21.1B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRME
FRME
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
FRME
FRME
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
FRME
FRME
PRCT
PRCT
Q1 26
$2.7B
$347.7M
Q4 25
$2.5B
$365.9M
Q3 25
$2.4B
$380.3M
Q2 25
$2.3B
$385.8M
Q1 25
$2.3B
$389.2M
Q4 24
$2.3B
$402.2M
Q3 24
$2.3B
$241.2M
Q2 24
$2.2B
$251.8M
Total Assets
FRME
FRME
PRCT
PRCT
Q1 26
$21.1B
$487.1M
Q4 25
$19.0B
$508.1M
Q3 25
$18.8B
$511.5M
Q2 25
$18.6B
$513.1M
Q1 25
$18.4B
$519.4M
Q4 24
$18.3B
$534.0M
Q3 24
$18.3B
$374.1M
Q2 24
$18.3B
$374.4M
Debt / Equity
FRME
FRME
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRME
FRME

Net Interest Income$151.3M96%
Noninterest Income$5.8M4%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons